erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the.

olczyk was excited that a bit of scheduling serendipity allowed him to work hockey in washington and horse racing in baltimore this week. more than anything, he's happy for the normalcy...ai-based software may help predict risk of dementia.